Related Experiment Video
Updated: Jan 13, 2026
14:18
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
2.2K
Current trial landscape of IgA nephropathy therapy
Jackson Kim1, Fahmeedah Kamal1, Richard Lafayette1
1Department of Nephrology, Stanford Hospital, Stanford University School of Medicine, Stanford, CA 94305, USA.
Med (New York, N.Y.)
|January 10, 2026
Summary
IgA nephropathy is seeing new targeted therapies beyond supportive care. Recent trials show promise in reducing proteinuria and preserving kidney function with novel treatments.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Immunoglobulin A (IgA) nephropathy is a chronic kidney disease.
- Current management primarily focuses on supportive care.
- There is a need for disease-targeted therapies.
Purpose of the Study:
- To summarize recent clinical progress in IgA nephropathy treatment.
- To highlight advancements in complement inhibition, endothelin receptor antagonism, and B cell/plasma-cell-directed therapies.
- To discuss the emerging framework for precision, biomarker-guided treatment.
Main Methods:
- Review of recent clinical trials and studies.
- Analysis of data on proteinuria reduction and renal function preservation.
- Evaluation of emerging treatment strategies.
Main Results:
- Promising reductions in proteinuria observed with new therapies.
- Evidence of renal function preservation in treated patients.
- Development of a precision medicine approach using biomarkers.
Conclusions:
- IgA nephropathy is entering a new era of targeted treatments.
- Complement inhibition, endothelin antagonism, and B cell therapies show significant potential.
- Biomarker-guided precision medicine is crucial for future treatment strategies.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
332
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
332
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
255
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
255
01:26Nephrotic Syndrome II : Assessment and Medical Management
189
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
189
01:24Nephrotic Syndrome III : Nursing Management
276
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
276
01:24Chronic Kidney Disease II: Clinical Manifestations
540
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
540
01:20Acute Kidney Injury V: Interprofessional Care
290
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
290